Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1065010.RATSX0SL0BnqR-bbokFHOd6PENnr2hF5xxw_2mTlOoN50130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1065010.RATSX0SL0BnqR-bbokFHOd6PENnr2hF5xxw_2mTlOoN50130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1065010.RATSX0SL0BnqR-bbokFHOd6PENnr2hF5xxw_2mTlOoN50130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1065010.RATSX0SL0BnqR-bbokFHOd6PENnr2hF5xxw_2mTlOoN50130_provenance.
- NP1065010.RATSX0SL0BnqR-bbokFHOd6PENnr2hF5xxw_2mTlOoN50130_assertion description "[This study provides important evidence for inhibition of hepatocellular carcinoma (HCC) growth by 15-PGDH through the 15-keto-prostaglandin E2 (15-keto-PGE2)/peroxisome proliferator-activated receptor-? (PPAR?)/p21(WAF1/Cip1) signaling pathway.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1065010.RATSX0SL0BnqR-bbokFHOd6PENnr2hF5xxw_2mTlOoN50130_provenance.
- NP1065010.RATSX0SL0BnqR-bbokFHOd6PENnr2hF5xxw_2mTlOoN50130_assertion evidence source_evidence_literature NP1065010.RATSX0SL0BnqR-bbokFHOd6PENnr2hF5xxw_2mTlOoN50130_provenance.
- NP1065010.RATSX0SL0BnqR-bbokFHOd6PENnr2hF5xxw_2mTlOoN50130_assertion SIO_000772 23542179 NP1065010.RATSX0SL0BnqR-bbokFHOd6PENnr2hF5xxw_2mTlOoN50130_provenance.
- NP1065010.RATSX0SL0BnqR-bbokFHOd6PENnr2hF5xxw_2mTlOoN50130_assertion wasDerivedFrom befree-2016 NP1065010.RATSX0SL0BnqR-bbokFHOd6PENnr2hF5xxw_2mTlOoN50130_provenance.
- NP1065010.RATSX0SL0BnqR-bbokFHOd6PENnr2hF5xxw_2mTlOoN50130_assertion wasGeneratedBy ECO_0000203 NP1065010.RATSX0SL0BnqR-bbokFHOd6PENnr2hF5xxw_2mTlOoN50130_provenance.
- befree-2016 importedOn "2016-02-19" NP1065010.RATSX0SL0BnqR-bbokFHOd6PENnr2hF5xxw_2mTlOoN50130_provenance.